PsiloTec is a biopharmaceutical company engaged in the development and delivery of integrated mental health therapies to address psychological and neurological mental health conditions. PsiloTec is focused on the research, development and commercialization of psychedelic-based compounds coupled with therapeutic treatment programs targeting a continuum of mental health conditions, such as MDD (major depressive disorder), TRD (treatment resistant depression), PTSD (post-traumatic stress disorder), general depression, anxiety disorders, and a number of addictive tendencies. PsiloTec aims to leverage leading technologies to support the scalability and accessibility of integrated therapy programs in its mission to enable those experiencing mental health challenges to thrive.

Recent News


private company